CLINICAL_TRIALS
research
· 2025-08-11
Clinical Trial Update: CGM Boosted by Artificial Intelligence for Better Glycaemic Control in T2 Diabetes
Summary
A clinical study evaluating AI-enhanced continuous glucose monitoring to improve glycemic control in Type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Erasme University Hospital | Conditions: Type 2 Diabetes | Status: ACTIVE_NOT_RECRUITING